Similar articles

• Are late potentials operative in arrhythmias following methylprednisolone pulse therapy.

  Ozen S, Tokgozoglu L, Saatci U. Ozen S, et al. Int J Cardiol. 1992 Aug;36(2):234-5. doi: 10.1016/0167-5273(92)90014-t. Int J Cardiol. 1992. PMID: 1512065
• Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents.

  Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM. Mendoza SA, et al. Pediatr Nephrol. 1990 Jul;4(4):303-7. doi: 10.1007/BF00862503. Pediatr Nephrol. 1990. PMID: 2206894
• Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.

  Vasheghani-Farahani A, Sahraian MA, Darabi L, Aghsaie A, Minagar A. Vasheghani-Farahani A, et al. J Neurol Sci. 2011 Oct 15;309(1-2):75-8. doi: 10.1016/j.jns.2011.07.018. Epub 2011 Aug 9. J Neurol Sci. 2011. PMID: 21831398
• How safe is it? High dose intravenous methylprednisolone.

  Ditzian-Kadanoff R, Ellman MH. Ditzian-Kadanoff R, et al. IMJ Ill Med J. 1987 Dec;172(6):432-4. IMJ Ill Med J. 1987. PMID: 2892818 Review. No abstract available.
• [Current therapeutic possibilities in chronic idiopathic glomerulonephritis].

  Ponticelli C, Fogazzi GB. Ponticelli C, et al. Minerva Urol Nefrol. 1985 Jan-Mar;37(1):9-12. Minerva Urol Nefrol. 1985. PMID: 3901338 Review. Italian. No abstract available.